Qube Research & Technologies (QRT)’s Indivior Pharmaceuticals INDV Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.2M	Sell	346,014 -83,349	-19%	-$3.02M	0.01%	1081
2026 Q1	$13.1M	Buy	+429,363	New	+$14.2M	0.01%	1119
2025 Q2	–	Sell	-239,389	Closed	-$2.28M	–	3738
2025 Q1	$2.28M	Sell	239,389 -347,902	-59%	-$3.66M	﹤0.01%	1903
2024 Q4	$7.3M	Buy	587,291 +314,142	+115%	+$3.23M	0.01%	1285
2024 Q3	$2.66M	Buy	273,149 +270,474	+10,111%	+$3.17M	﹤0.01%	1658
2024 Q2	$43.1K	Sell	2,675 -49,627	-95%	-$896K	﹤0.01%	2772
2024 Q1	$1.12M	Buy	52,302 +32,616	+166%	+$613K	﹤0.01%	2079
2023 Q4	$301K	Buy	19,686 +17,884	+992%	+$318K	﹤0.01%	2574
2023 Q3	$40.7K	Buy	+1,802	New	+$41.1K	﹤0.01%	2932

Other funds holding INDV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s INDV Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Indivior Pharmaceuticals (INDV) stake by 19% in Q2 2026, selling an estimated $3.02M and leaving 346,014 shares worth $14.2M. The position accounts for 0.01% of the portfolio, ranked #1081.

Qube Research & Technologies (QRT) first reported a position in INDV in Q3 2023 and has held it in 9 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

Qube Research & Technologies (QRT) held 346,014 shares of Indivior Pharmaceuticals worth $14.2M as of Q2 2026.
Qube Research & Technologies (QRT) sold 83,349 Indivior Pharmaceuticals shares in Q2 2026, an estimated $3.02M.
Indivior Pharmaceuticals made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1081 holding.
Qube Research & Technologies (QRT) first reported a position in Indivior Pharmaceuticals in Q3 2023 and has held it in 9 quarters since.
338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.